Clark Capital Management Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.2M | Sell |
11,134
-199
| -2% | -$21.4K | 0.01% | 288 |
|
2025
Q1 | $1.14M | Buy |
11,333
+6,694
| +144% | +$675K | 0.01% | 287 |
|
2024
Q4 | $414K | Buy |
4,639
+404
| +10% | +$36.1K | ﹤0.01% | 345 |
|
2024
Q3 | $355K | Buy |
4,235
+80
| +2% | +$6.7K | ﹤0.01% | 352 |
|
2024
Q2 | $320K | Buy |
4,155
+52
| +1% | +$4.01K | ﹤0.01% | 346 |
|
2024
Q1 | $281K | Buy |
+4,103
| New | +$281K | ﹤0.01% | 357 |
|
2020
Q1 | – | Sell |
-5,253
| Closed | -$238K | – | 283 |
|
2019
Q4 | $238K | Sell |
5,253
-171
| -3% | -$7.75K | 0.01% | 298 |
|
2019
Q3 | $221K | Buy |
+5,424
| New | +$221K | 0.01% | 290 |
|
2014
Q1 | – | Sell |
-13,082
| Closed | -$157K | – | 340 |
|
2013
Q4 | $157K | Sell |
13,082
-613
| -4% | -$7.36K | 0.01% | 328 |
|
2013
Q3 | $161K | Sell |
13,695
-1,065
| -7% | -$12.5K | 0.01% | 328 |
|
2013
Q2 | $137K | Buy |
+14,760
| New | +$137K | 0.01% | 321 |
|